Tropical Panned

Description

The product identified by SPL code 34089-3 is indicated for the treatment of heartburn.

Uses and Indications

This drug is indicated for the relief of acid indigestion, heartburn, sour stomach, and upset stomach associated with these symptoms. Additionally, it provides relief from bloating, pressure, or the stuffed feeling commonly referred to as gas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are instructed to fully chew and then swallow 1 or 2 chewable tablets as symptoms occur, or as directed by a healthcare professional. For children under 12 years of age, consultation with a doctor is recommended prior to administration.

It is imperative that no more than 5 chewable tablets are taken within a 24-hour period to avoid potential overdose or adverse effects.

Contraindications

Use of this product is contraindicated in the following situations:

Patients should not exceed a maximum dosage of 5 chewable tablets within a 24-hour period. Additionally, the maximum dosage should not be used for more than 2 weeks unless under the advice and supervision of a physician. These restrictions are in place to mitigate potential risks associated with excessive use.

Warnings and Precautions

The use of this product is contraindicated in individuals with a history of allergic reactions to the product or any of its components. Healthcare professionals should ensure that patients are thoroughly screened for any previous hypersensitivity to the formulation prior to administration.

No additional general precautions or laboratory tests have been specified for the safe use of this product. It is essential for healthcare providers to remain vigilant and monitor patients for any signs of adverse reactions, particularly in those with known allergies.

Side Effects

Patients should be aware that the use of this product is contraindicated in individuals who have a history of allergic reactions to the product or any of its ingredients. This warning is critical to prevent serious allergic responses that may occur upon administration.

In clinical trials and postmarketing experiences, no additional adverse reactions have been reported beyond those associated with allergic reactions. Therefore, careful consideration should be given to the patient's medical history prior to prescribing this product to mitigate the risk of serious adverse events.

Drug Interactions

Antacids may interact with various prescription medications, potentially affecting their absorption and efficacy. It is advisable to separate the administration of antacids and other medications by at least two hours to minimize the risk of interaction. Monitoring for therapeutic effectiveness of the affected drugs is recommended when antacids are used concurrently.

Packaging & NDC

Below are the non-prescription pack sizes of Tropical Panned (calcium carbonate, simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a doctor before use. For adolescents and children aged 12 years and older, the recommended dosage is to fully chew and then swallow 1 or 2 chewable tablets as symptoms occur, or as directed by a healthcare professional. It is important to note that no more than 5 chewable tablets should be taken within a 24-hour period.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous assessment and supportive measures should be prioritized until the patient stabilizes or further treatment is determined.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is vital for ongoing management and potential reporting requirements.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified reports of constipation associated with the use of this product. These events were reported voluntarily or through surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. When using this product, patients should be instructed not to exceed a maximum of 5 chewable tablets within a 24-hour period. Additionally, they should be cautioned against using the maximum dosage for more than 2 weeks unless directed and supervised by a physician.

Patients should also be made aware that constipation may occur as a side effect of this product. It is important for healthcare providers to recommend that patients consult with a doctor or pharmacist prior to use if they are currently taking any prescription medications, as antacids may interact with certain drugs.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is crucial to store the product at room temperature, ensuring that it is kept away from excessive heat, particularly temperatures exceeding 40°C (104°F).

To maintain the integrity of the product, the cap must be closed tightly after each use. This practice helps to prevent contamination and preserves the quality of the contents.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Tropical Panned, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)